Efficacy and safety of metronomic cyclophosphamide combined with abiraterone and dexamethasone in heavily pretreated metastatic castration-resistant prostate cancer: A retrospective, real-world study.

MLA

Zhang, Lulu, et al. “Efficacy and Safety of Metronomic Cyclophosphamide Combined with Abiraterone and Dexamethasone in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: A Retrospective, Real-World Study.” Asian Journal of Surgery, vol. 47, no. 8, Aug. 2024, pp. 3577–78. EBSCOhost, https://doi.org/10.1016/j.asjsur.2024.03.149.

APA

Zhang, L., Zhou, L., Shi, Y., & An, X. (2024). Efficacy and safety of metronomic cyclophosphamide combined with abiraterone and dexamethasone in heavily pretreated metastatic castration-resistant prostate cancer: A retrospective, real-world study. Asian Journal of Surgery, 47(8), 3577–3578. https://doi.org/10.1016/j.asjsur.2024.03.149

Chicago

Zhang, Lulu, Lijia Zhou, Yanxia Shi, and Xin An. 2024. “Efficacy and Safety of Metronomic Cyclophosphamide Combined with Abiraterone and Dexamethasone in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: A Retrospective, Real-World Study.” Asian Journal of Surgery 47 (8): 3577–78. doi:10.1016/j.asjsur.2024.03.149.